Developing exosomal therapies for diseases August 7, 2020 by Llewellyn King talks with Linda Marban, CEO of Capricor Therapeutics, about the exosomal path to developing a vaccine for COVID-19 and Duchenne Muscular Dystrophy, and the excitement of medical research.